Quest Diagnostics 2010 Annual Report Download - page 68

QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
DECEMBER 31, 2010 AND 2009
(in thousands, except per share data)
2010 2009
Assets
Current assets:
Cash and cash equivalents ......................................................... $ 449,301 $ 534,256
Accounts receivable, net of allowance for doubtful accounts of $228,917 and
$238,206 at December 31, 2010 and 2009, respectively . . ......................... 845,299 827,343
Inventories. . ...................................................................... 76,572 91,386
Deferred income taxes ............................................................ 142,470 131,800
Prepaid expenses and other current assets .......................................... 91,775 94,640
Total current assets ........................................................... 1,605,417 1,679,425
Property, plant and equipment, net .............................................. 834,376 825,946
Goodwill ......................................................................... 5,101,938 5,083,944
Intangible assets, net ............................................................. 796,405 823,665
Other assets...................................................................... 189,494 150,663
Total assets ...................................................................... $ 8,527,630 $ 8,563,643
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable and accrued expenses . ........................................... $ 865,272 $ 888,705
Current portion of long-term debt .................................................. 348,996 170,507
Total current liabilities........................................................ 1,214,268 1,059,212
Long-term debt .................................................................. 2,641,160 2,936,792
Other liabilities .................................................................. 618,077 556,175
Commitments and contingencies
Stockholders’ equity:
Quest Diagnostics stockholders’ equity:
Common stock, par value $0.01 per share; 600,000 shares authorized at both
December 31, 2010 and 2009; 214,173 shares and 214,110 shares issued at
December 31, 2010 and 2009, respectively ....................................... 2,142 2,141
Additional paid-in capital.......................................................... 2,311,421 2,302,368
Retained earnings ................................................................. 3,867,420 3,216,639
Accumulated other comprehensive income (loss). . .................................. 10,626 (20,961)
Treasury stock, at cost; 43,456 shares and 30,817 shares at December 31, 2010 and
2009, respectively . ............................................................. (2,158,129) (1,510,548)
Total Quest Diagnostics stockholders’ equity . . . .................................. 4,033,480 3,989,639
Noncontrolling interests ........................................................... 20,645 21,825
Total stockholders’ equity. .................................................... 4,054,125 4,011,464
Total liabilities and stockholders’ equity ......................................... $ 8,527,630 $ 8,563,643
The accompanying notes are an integral part of these statements.
F-2